Alternative livelihood training programme for rural women who are employed in the tobacco industry in India

Ms Sheeba Paul - Exodus Exports Pvt Ltd, Chennai, India
Alternative livelihood training programme for rural women who are employed in the tobacco industry in India ( Ms Sheeba Paul - Exodus Exports Pvt Ltd, Chennai, India )
23 Oct 2024

Navigating cancer treatment choices

Dr Shriniwas Kulkarni - Sahyadri Superspeciality Hospital,Pune, India
Navigating cancer treatment choices ( Dr Shriniwas Kulkarni - Sahyadri Superspeciality Hospital,Pune, India )
10 Oct 2024

Choosing Wisely in endometrial & cervix cancers: BMC data

Dr Indu Bansal - Paras Health, Gurgaon, India
Choosing Wisely in endometrial & cervix cancers: BMC data ( Dr Indu Bansal - Paras Health, Gurgaon, India )
22 Sep 2024

Choosing Wisely in endometrial & cervix cancers: Surgery

Dr Deepti Mishra - Tangham Cancer Center, Uttar Pradesh, India
Choosing Wisely in endometrial & cervix cancers: Surgery ( Dr Deepti Mishra - Tangham Cancer Center, Uttar Pradesh, India )
22 Sep 2024

Choosing Wisely in endometrial & cervix cancers: Medical therapy

Dr Jaya Ghosh - Tata Memorial Hospital, Mumbai, India
Choosing Wisely in endometrial & cervix cancers: Medical therapy ( Dr Jaya Ghosh - Tata Memorial Hospital, Mumbai, India )
22 Sep 2024

PFS increase but no OS increase for niraparib in advanced ovarian cancer

Dr Antonio González-Martín - Cancer Center Clínica Universidad de Navarra, Madrid, Spain
PFS increase but no OS increase for niraparib in advanced ovarian cancer ( Dr Antonio González-Martín - Cancer Center Clínica Universidad de Navarra, Madrid, Spain )
17 Sep 2024

Novel antibody drug conjugate TORL-1-23 shows preliminary antitumour activity in heavily-pretreated ovarian, endometrial, and testicular cancers

Prof Gottfried Konecny - University of California, Los Angeles, USA
Novel antibody drug conjugate TORL-1-23 shows preliminary antitumour activity in heavily-pretreated ovarian, endometrial, and testicular cancers ( Prof Gottfried Konecny - University of California, Los Angeles, USA )
16 Sep 2024

Mirvetuximab soravtansine shows promise in FRα-positive, platinum-sensitive ovarian cancer

Dr Angeles Alvarez Secord - Duke Cancer Center, Durham, USA
Mirvetuximab soravtansine shows promise in FRα-positive, platinum-sensitive ovarian cancer ( Dr Angeles Alvarez Secord - Duke Cancer Center, Durham, USA )
16 Sep 2024

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies

Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA
ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies ( Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA )
14 Sep 2024

Assessment of suicide risk in cancer patients

Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India
Assessment of suicide risk in cancer patients ( Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India )
10 Sep 2024

Association of adult attachment with delays in accessing specialist care in women with ovarian cancer

Dr Soumitra S. Datta - Tata Medical Center, Kolkata, India
Association of adult attachment with delays in accessing specialist care in women with ovarian cancer ( Dr Soumitra S. Datta - Tata Medical Center, Kolkata, India )
7 Sep 2024

Cancer journeys: Research from India

Ms. Soumita Ghose - Tata Medical Center, Kolkata
Cancer journeys: Research from India ( Ms. Soumita Ghose - Tata Medical Center, Kolkata )
7 Sep 2024